Biotech · Private company · Cambridge, MA, US
Thymmune Therapeutics, Inc
Track this companyFree. Adds Thymmune Therapeutics, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Development of a stem-cell derived thymic cell therapy to treat patients with athymiaFiscal year 2026 · $1MNIH RePORTER 5R44AI170266-05 · fetched Nov 12, 2026
- Development of a stem-cell derived thymic cell therapy to treat patients with athymiaFiscal year 2025 · $1MNIH RePORTER 5R44AI170266-04 · fetched Nov 12, 2026
- Development of a stem-cell derived thymic cell therapy to treat patients with athymiaFiscal year 2024 · $1MNIH RePORTER 4R44AI170266-03 · fetched Nov 12, 2026